A type of immune cell that contributes to inflammatory bowel disease exists in two forms, ‘good’ and ‘bad.’ A new Crick-led study in Immunity has characterized these distinct populations, which could help scientists to develop treatments targeting inflammation while preserving healthy gut function.
Source: EurekaAlert, https://www.eurekalert.org